Form 4 for CRMD CorMedix Inc.
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-24 · accession 0001213900-25-115725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-26 | 2025-11-24 | CRMD | Dillione Janet | Dir | M - OptEx | $3.64 | +26.3K | 56.5K | +87% | +$95.9K |
| D | 2025-11-26 | 2025-11-24 | CRMD | Dillione Janet | Dir | S - Sale+OE | $9.93 | -26.3K | 48.5K | -35% | -$261.6K |
| DM | 2025-11-26 | 2025-11-24 | CRMD | Dillione Janet | Dir | M - OptEx | $0.00 | -26.3K | 24.3K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-24 | M | A | 7,790 | $4.03 | 64,263 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-24 | M | A | 5,677 | $3.55 | 74,816 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-24 | M | A | 4,876 | $4.43 | 69,139 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-24 | M | A | 8,000 | $2.85 | 56,473 | D | — | — | |
| 5 | Common | Common Stock | 2025-11-24 | S | D | 26,343 | $9.93 | 48,473 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $9.72 to $10.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 6 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-11-24 | M | D | 7,790 | $0.00 | 12,210 | D | $4.03 · — to 2032-02-22 | 7,790 Common Stock | (F3) These options were granted on 02/22/2022. These options are fully vested. |
| 7 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-11-24 | M | D | 8,000 | $0.00 | 0 | D | $2.85 · — to 2028-02-16 | 8,000 Common Stock | (F2) These options were granted on 02/16/2018. These options are fully vested. |
| 8 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-11-24 | M | D | 4,876 | $0.00 | 15,124 | D | $4.43 · — to 2033-01-14 | 4,876 Common Stock | (F4) These options were granted on 01/14/2023. These options are fully vested. |
| 9 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-11-24 | M | D | 5,677 | $0.00 | 24,323 | D | $3.55 · — to 2034-03-05 | 5,677 Common Stock | (F5) These options were granted on 03/05/2024. These options are fully vested. |